Insights

Health

Tripling down on bio
Health
5 May 2022

Tripling down on bio

Why Octopus Ventures is investing in European biotech and the areas we think will produce the next wave of breakout bioscience businesses
Written by Uzma Choudry
Our investment in Automata
HealthPortfolio
1 Mar 2022

Our investment in Automata

Automata is helping scientists achieve better results faster with automated lab solutions. Read why Octopus Ventures have led their latest investment round
Written by Jess McCreadie
Our investment in Biofidelity
HealthPortfolio
1 Mar 2022

Our investment in Biofidelity

Octopus Ventures investment in Biofidelity. Understand the who and why behind our latest deal announcement
Written by Uzma Choudry
Our investment in Tuune
HealthPortfolio
1 Nov 2021

Our investment in Tuune

Millions of women struggle with side effects related to contraception, here’s how Tuune will solve it
Written by Uzma Choudry
Our Investment in Imophoron
HealthPortfolio
20 Oct 2021

Our Investment in Imophoron

Imophoron is aiming to revolutionise the vaccine industry with its disruptive new technology.
Written by Uzma Choudry
Our investment in Mojo
HealthPortfolio
27 Sep 2021

Our investment in Mojo

Our latest investment, Mojo is a sexual wellbeing platform for men which is providing an entirely pill free, digital solution.
Written by Kamran Adle
Our investment in Overture
HealthPortfolio
10 Jun 2021

Our investment in Overture

Who are the pioneers? Overture was co-founded by Martin Varsavsky (CEO) in 2017. Martin is a serial entrepreneur who has built and exited several...
Written by Luke Hakes